ATIN — Athanase Innovation AB Income Statement
0.000.00%
- SEK467.10m
- SEK21.27m
- SEK19.27m
- 43
- 24
- 33
- 23
Annual income statement for Athanase Innovation AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 42 | 42.4 | 7.06 | 6.38 | 19.3 |
Cost of Revenue | |||||
Gross Profit | 41.1 | 41.4 | — | — | — |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 33.8 | 34.1 | 37.4 | 130 | 86.5 |
Operating Profit | 8.28 | 8.3 | -30.3 | -124 | -67.2 |
Net Income Before Taxes | 8.28 | 8.3 | -30.3 | -124 | -67.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 6.3 | 6.19 | -26.6 | -115 | -56.3 |
Net Income Before Extraordinary Items | |||||
Net Income | 6.3 | 6.19 | -26.6 | -115 | -56.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 6.3 | 6.19 | -26.6 | -115 | -56.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 33.6 | 33 | -0.489 | -3.69 | -1.88 |
Dividends per Share |